SCAI/HFSA clinical expert consensus document on the use of invasive hemodynamics for the diagnosis and management of cardiovascular disease

Catheterization and Cardiovascular Interventions

Volumn 89, Issue 7, 2017, Pages E233-E247

  Sorajja, Paul ^a   Borlaug, Barry A ^b   Dimas, Vasiliki V ^c   Fang, James C ^d   Forfia, Paul R ^e   Givertz, Michael M ^f   Kapur, Navin K ^g   Kern, Morton J ^h   Naidu, Srihari S ⁱ  

^a ABBOTT NORTHWESTERN HOSPITAL   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^e TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

^g TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ WESTCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD FLOW; BLOOD VESSEL CAPACITANCE; CARDIOGENIC SHOCK; CARDIOVASCULAR DISEASE; CONGENITAL HEART DISEASE; DIASTOLE; EDITORIAL; HEART AFTERLOAD; HEART HEMODYNAMICS; HEART MUSCLE COMPLIANCE; HEART MUSCLE CONTRACTILITY; HEART OUTPUT; HEART PRELOAD; HEART RIGHT VENTRICLE; HEART VENTRICLE PRESSURE; HEART VOLUME; HEART WORK; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMPEDANCE; INVASIVE PROCEDURE; LUNG RESISTANCE; MEDICAL DOCUMENTATION; MEDICAL EDUCATION; PERICARDIAL DISEASE; PULMONARY HYPERTENSION; SYSTOLE; VALVULAR HEART DISEASE; VENTRICULAR ASSIST DEVICE; BIOLOGICAL MODEL; CARDIOVASCULAR SYSTEM; CONSENSUS; HEART CATHETERIZATION; HEART LEFT VENTRICLE FUNCTION; HEART RIGHT VENTRICLE FUNCTION; HEMODYNAMICS; MEDICAL SOCIETY; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PREDICTIVE VALUE; STANDARDS;

CARDIAC CATHETERIZATION; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; CONSENSUS; HEMODYNAMICS; HUMANS; MODELS, CARDIOVASCULAR; PREDICTIVE VALUE OF TESTS; SOCIETIES, MEDICAL; VENTRICULAR FUNCTION, LEFT; VENTRICULAR FUNCTION, RIGHT;

EID: 85019052796     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.26888     Document Type: Editorial

References (59)

1. Jaber WA, Sorajja P, Borlaug BA, Nishimura RA. Differentiation of tricuspid regurgitation from constrictive pericarditis: Novel criteria for diagnosis in the cardiac catheterization laboratory. Heart 2009;95:1449–1454.
2. Borlaug BA, Nishimura RA, Sorajja P, et al. Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction. Circ Heart Fail 2010;3:588–595.
3. Hurrell DG, Nishimura RA, Higano ST, et al. Value of dynamic respiratory changes in left and right ventricular pressures for the diagnosis of constrictive pericarditis. Circulation 1996;93:2007–2013.
4. Talreja DR, Nishimura RA, Oh JK, Holmes DR Jr. Constrictive pericarditis in the modern era: Novel criteria for diagnosis in the modern era. J Am Coll Cardiol 2008;51:315–319.
5. Narang N, Thibodeau JT, Levine BD, et al. Inaccuracy of estimated resting oxygen uptake in the clinical setting. Circulation 2014;129:203–210.
6. Andersen MJ, Borlaug BA. Invasive hemodynamic characterization of heart failure with preserved ejection fraction. Heart Fail Clin 2014;10:435–444.
7. Borlaug BA, Kass DA. Invasive hemodynamic assessment in heart failure. Cardiol Clin 2011;29:269–280.
8. Kelly RP, Ting CT, Yang TM, Liu CP, Maughan WL, Chang MS, Kass DA. Effective arterial elastance as index of arterial vascular load in humans. Circulation 1992;86:513–521.
9. Borlaug BA, Kass DA. Ventricular-vascular interaction in heart failure. Cardiol Clin 2011;29:447–459.
10. Zile M, Baicu CF, Gaasch WH. Diastolic heart failure—Abnormalites in active relaxation and passive stiffness of the left ventricle. N Engl J Med 2004;350:1953–1959.
11. Schwartzenberg S, Redfield MM, From AM, Sorajja P, Nishimura RA, Borlaug BA. Effects of vasodilation in heart failure with preserved or reduced ejection fraction implications of distinct pathophysiologies on response to therapy. J Am Coll Cardiol 2012;59:442–451.
12. Kawaguchi M, Hay I, Fetics B, Kass DA. Combined ventricular systolic and arterial stiffening in patients with heart failure and preserved ejection fraction: Implications for systolic and diastolic reserve limitations. Circulation 2003;107:714–720.
13. Kass DA, Maughan WL, Guo ZM, et al. Comparative influence of load versus inotropic states on indexes of ventricular contractility: Experimental and theoretical analysis based on pressure-volume relationships. Circulation 1987;76:1422–1436.
14. Kass DA, Maughan WL. From ‘Emax’ to pressure-volume relations: A broader view. Circulation 1988;77:1203–1212.
15. Cotter G, Moshkovitz Y, Kaluski E, et al. The role of cardiac power and systemic vascular resistance in the pathophysiology and diagnosis of patients with acute congestive heart failure. Eur J Heart Fail 2003;5:443–451.
16. Mendoza DD, Cooper HA, Panza JA. Cardiac power output predicts mortality across a broad spectrum of patients with acute cardiac disease. Am Heart J 2007;153:366–370.
17. Fincke R, Hochman JS, Lowe AM, et al. Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: A report from the SHOCK trial registry. J Am Coll Cardiol 2004;44:340–348.
18. Lewis GD, Bossone E, Naeije R, et al. Pulmonary vascular hemodynamic response to exercise in cardiopulmonary diseases. Circulation 2013;128:1470–1479.
19. Tedford RJ, Hassoun PM, Mathai SC, et al. Pulmonary capillary wedge pressure augments right ventricular pulsatile loading. Circulation 2012;125:289–297.
20. Eleid MF, Nishimura RA, Sorajja P, Borlaug BA. Systemic hypertension in low-gradient severe aortic stenosis with preserved ejection fraction. Circulation 2013;128:1349–1353.
21. Borlaug BA, Lam CS, Roger VL, Rodeheffer RJ, Redfield MM. Contractility and ventricular systolic stiffening in hypertensive heart disease insights into the pathogenesis of heart failure with preserved ejection fraction. J Am Coll Cardiol 2009;54:410–418.
22. Baicu CF, Zile MR, Aurigemma GP, Gaasch WH. Left ventricular systolic performance, function, and contractility in patients with diastolic heart failure. Circulation 2005;111:2306–2312.
23. Kass DA. Assessment of diastolic dysfunction: Invasive modalities. Cardiol Clin 2000;18:571–586.
24. Andersen MJ, Nishimura RA, Borlaug BA. The hemodynamic basis of exercise intolerance in tricuspid regurgitation. Circ Heart Fail 2014;7:911. 7:
25. Atherton JJ, Moore TD, Lele SS, Thomson HL, Galbraith AJ, Belenkie I, Tyberg JV, Frenneaux MP. Diastolic ventricular interaction in chronic heart failure. Lancet 1997;349:1720–1724.
26. Abudiab MM, Redfield MM, Melenovsky V, et al. Cardiac output response to exercise in relation to metabolic demand in heart failure with preserved ejection fraction. Eur J Heart Fail 2013;15:776–785.
27. Alaeddini J, Uber PA, Park MH, Scott RL, Ventura HO, Mehra MR. Efficacy and safety of sildenafil in the evaluation of pulmonary hypertension in severe heart failure. Am J Cardiol 2004;94:1475–1477.
28. Raina A, Seetha Rammohan HR, Gertz ZM, et al. Postoperative right ventricular failure after left ventricular assist device placement is predicted by preopeartiv echocardiographic structural, hemodynamic, and functional parameters. J Card Fail 2013;19:16–24.
29. Rain A, Nadziakiewicz P, Niklewski T, Szygula-Jurkiewicz B, et al. Preoperative echocardiography examination of right ventricle function in patients scheduled for LVAD implantation correlates with postoperative hemodynamic examinations. Ann Transplant 2016;21:500–507.
30. Herve P, Lau Em, Sitbon O, et al. Criteria for diagnosis of exercise pulmonary hypertension. Eur Respir J 2015;46:728–737.
31. Masutani S, Senzaki H. Left ventricular function in adult patients with atrial septal defect: Implication for development of heart failure after transcatheter closure. J Card Fail 2011;17:957–963.
32. Webb G, Gatzoulis MA. Congenital heart disease for the adult cardiologist. Circulation 2006;114:1645–1653.
33. Shaddy RE, Webb G. Applying heart failure guidelines to adult congenital heart disease patients. Expert Rev Cardiovasc Ther 2008;6165–6174.
34. Warnes CA, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA, Del Nido P, Fasules JW, Graham TP, Hijazi ZM, Hunt SA, King ME, Landzberg MJ, Miner PD, Radford MJ, Walsh EP, Webb GD. ACC/AHA 2008 Guidelines for the management of adults with congenital heart disease. Circulation 2008;118:e714–e833.
35. Feltes TF, Bacha E, Beekman IIIRH, Cheatham JP, Feinstein JA, Gomes AS, Hijazi ZM, Ing FF, De Moor M, Morrow WR, Mullins CE, Taubert KA, Zahn EM. Indications for cardiac catheterization and intervention in pediatric cardiac disease. A scientific statement from the American Heart Association. Circulation 2011;123:2607–2652.
36. Grimaldi A, Vermi AC, Maisano F, Sacco F, Castiglioni A, Zangrillo A, Alfieri O. Echocardiographic patterns of incomplete Shone's syndrome in adults. J Heart Valve Dis 2011;20:552–556.
37. Asante-Korang A, O'Leary PW, Anderson RH. Anatomy and echocardiography of the normal and abnormal mitral valve. Cardiol Young 2006;16:27–34.
38. Ma XJ, Huang GY, Liu XQ, Jia B. Atypical Shone's complex diagnosed by echocardiography. Pediatr Cardiol 2011;32:442–448.
39. St Louis JD, Banna MM, Lutin WA, Wiles HB. Surgical strategies and outcomes in patients with Shone complex: A retrospective review. Ann Thorac Surg 2007;84:1357–1362.
40. Jaber W, Nishimura RA, Ommen SR. Not all systolic velocities indicate obstruction in hypertrophic cardiomyopathy: A simultaneous Doppler catheterization study. J Am Soc Echocardiogr 2007;1009:e5–e7.
41. Geske JB, Cullen MW, Sorajja P, Ommen SR, Nishimura RA. Assessment of left ventricular outflow gradient: Hyperrophic cardiomyopathy versus aortic valvular stenosis. JACC Cardiovasc Interv 2012;5:675–681.
42. Geske J, Sorajja P, Nishimura RA, Ommen SR. Variability of the left ventricular outflow tract gradient variability during cardiac catheterization in hypertrophic cardiomyopathy. JACC Cardiovasc Intervent 2011;4:704–709.
43. Elesber A, Nishimura RA, Rihal CS, Ommen SR, Schaff HV, Holmes DR Jr. Utility of isoproterenol to provoke outflow tract gradients in patients with hypertrophic cardiomyopathy. Am J Cardiol 2008;101:516–520.
44. Kapur N, Jumean M. Interventions for Advanced Heart Failure. In: Bhatt D, editor., Cardiovascular Intervention: A Companion to Braunwald's Heart Disease. Boston, MA. Elsevier; 2015. pp. 543–561
45. Sarnoff SJ, Braunwald E, Welch GH Jr, et al. Hemodynamic determinants of oxygen consumption of the heart with special reference to the tension-time index. Am J Physiol 1958;192:148–156.
46. Antonelli M, Levy M, Andrews PJ, et al. Hemodynamic monitoring in shock and implications for management. International Consensus Conference, Paris, France, 27–28 April 2006. Intensive Care Med 2007;33:575–590.
47. Reynolds HR, Hochman JS. Cardiogenic shock: Current concepts and improving outcomes. Circulation 2008;117:686–697.
48. Topalian S, Ginsberg F, Parrillo JE. Cardiogenic shock. Crit Care Med 2008;36:S66–S74.
49. Bregman D, Nichols AB, Weiss MB, Powers ER, Martin EC, Casarella WJ. Percutaneous intraaortic balloon insertion. Am J Cardiol 1980;46:261–264.
50. Kapur NK, Steinberg D. Cardiogenic Shock. In Kern (Ed), SCAI Interventional Board Review (pp. 223-230). Lippincott Williams and Wilkins, Philadelphia, PA.De Silva K, Lumley M, Kailey B, et al. Coronary and microvascular physiology during intra-aortic balloon counterpulsation. JACC Cardiovasc Interv 2014;7:631–640.
51. Nativi-Nicolau J, Selzman CH, Fang JC, Stehlik J. Pharmacologic therapies for acute cardiogenic shock. Curr Opin Cardiol 2014;29:250–257.
52. Sintek MA, Gdowski M, Lindman BR, Nassif M, Lavine KJ, Novak E, Bach RG, Silvestry SC, Mann DL, Joseph SM. Intra-Aortic Balloon counterpulsation in patients with chronic heart failure and cardiogenic shock: Clinical response and predictors of stabilization. J Card Fail 2015;21:868–876.
53. Kapur NK, Paruchuri V, Majithia A, Esposito M, Shih H, Weintraub A, Kiernan M, Pham DT, Denofrio D, Kimmelstiel C. Hemodynamic effects of standard versus larger-capacity intraaortic balloon counterpulsation pumps. J Invasive Cardiol 2015;27:182–188.
54. Kapur NK, Paruchuri V, Pham DT, Reyelt L, Murphy B, Beale C, Bogins C, Wiener D, Nilson J, Esposito M, Perkins S, Perides G, Karas RH. Hemodynamic effects of left atrial or left ventricular cannulation for acute circulatory support in a bovine model of left heart injury. Asaio J 2015;61:301–306.
55. Rihal CS, Naidu SS, Givertz MM, Szeto WY, Burke JA, Kapur NK, Kern M, Garratt KN, Goldstein JA, Dimas V, Tu T. Society for Cardiovascular Angiography and Interventions (SCAI), Heart Failure Society of America (HFSA), Society for Thoracic Surgeons (STS), American Heart Association (AHA), and American College of Cardiology (ACC). 2015 SCAI/ACC/HFSA/STS clinical expert consensus statement on the use of percutaneous mechanical circulatory support devices in cardiovascular care (Endorsed by the American heart assocation, the cardiological society of India, and sociedad latino Americana de cardiologia intervencion; Affirmation of value by the canadian association of interventional cardiology-association canadienne de cardiologie d'intervention). Catheter Cardiovasc Interv 2015;85:E175–E196.
56. Chauhan S, Subin S. Extracorporeal membrane oxygenation, an anesthesiologist's perspective: Physiology and principles. Part 1. Ann Card Anaesth 2011;14:218–229.
57. Aghili N, Kang S, Kapur NK. The fundamentals of extra-corporeal membrane oxygenation. Minerva Cardioangiol 2015;63:75–85.
58. Kapur NK, Jumean MF. Defining the role for percutaneous mechanical circulatory support devices for medically refractory heart failure. Curr Heart Fail Rep 2013;10:177–184.
59. Morine KJ, Kapur NK. Percutaneous mechanical circulatory support for cardiogenic shock. Curr Treat Options Cardiovasc Med 2016;18:6.